Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

bintrafusp alfa (M7824)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

EMD Serono

Drug class:

PD-L1 inhibitor, TGFβ inhibitor

Related drugs:

‹

sotatercept-csrk (0)

atezolizumab (236)

durvalumab (199)

benmelstobart (12)

sugemalimab (7)

envafolimab (6)

IO102-IO103 (4)

socazolimab (2)

atezolizumab and hyaluronidase-tqjs (1)

adebrelimab (0)

CF33-hNIS-antiPDL1 (0)

PD-L1.t-haNK (0)

PF-07257876 (0)

Undisclosed anti-PD-L1 antibody (0)

cosibelimab-ipdl (0)

luspatercept-aamt (4)

sotatercept-csrk (0)

›

PD-L1 overexpression	Non Small Cell Lung Cancer	PD-L1 overexpression	Non Small Cell Lung Cancer	M7824 Sensitive: B - Late Trials M7824 Sensitive : B	M7824 Sensitive: B - Late Trials M7824 Sensitive : B
TMB-H	Non Small Cell Lung Cancer	TMB-H	Non Small Cell Lung Cancer	M7824 Sensitive: B - Late Trials M7824 Sensitive : B	M7824 Sensitive: B - Late Trials M7824 Sensitive : B
PD-L1 expression	Biliary Tract Cancer	PD-L1 expression	Biliary Tract Cancer	M7824 Sensitive: C2 – Inclusion Criteria M7824 Sensitive : C2	M7824 Sensitive: C2 – Inclusion Criteria M7824 Sensitive : C2
MSI-H/dMMR	Solid Tumor	MSI-H/dMMR	Solid Tumor	M7824 Resistant: C3 – Early Trials M7824 Resistant : C3	M7824 Resistant: C3 – Early Trials M7824 Resistant : C3
TGFB1 elevation	Gastroesophageal Cancer	TGFB1 elevation	Gastroesophageal Cancer	M7824 Sensitive: C3 – Early Trials M7824 Sensitive : C3	M7824 Sensitive: C3 – Early Trials M7824 Sensitive : C3
TGFB1 elevation	Gastric Cancer	TGFB1 elevation	Gastric Cancer	M7824 Sensitive: C3 – Early Trials M7824 Sensitive : C3	M7824 Sensitive: C3 – Early Trials M7824 Sensitive : C3
IFNG expression	Colorectal Cancer	IFNG expression	Colorectal Cancer	M7824 Sensitive: C3 – Early Trials M7824 Sensitive : C3	M7824 Sensitive: C3 – Early Trials M7824 Sensitive : C3
IDH2 mutation	Glioblastoma	IDH2 mutation	Glioblastoma	M7824 Sensitive: C3 – Early Trials M7824 Sensitive : C3	M7824 Sensitive: C3 – Early Trials M7824 Sensitive : C3
KRAS mutation + PD-L1 expression	Colorectal Cancer	KRAS mutation + PD-L1 expression	Colorectal Cancer	M7824 Sensitive: C4 – Case Studies M7824 Sensitive : C4	M7824 Sensitive: C4 – Case Studies M7824 Sensitive : C4